Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer.
about
Exploring the role of molecular biomarkers as a potential weapon against gastric cancer: A review of the literaturePerspectives on new biomarkers in gastric cancer: diagnostic and prognostic applicationsEnvironmental chemical exposures and human epigeneticsDetection of aberrant promoter methylation of RNF180, DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer.Pathogenetic mechanisms in gastric cancer.Biomarkers for gastric cancer: Progression in early diagnosis and prognosis (Review).Large-scale characterization of DNA methylation changes in human gastric carcinomas with and without metastasis.HOXA11 gene is hypermethylation and aberrant expression in gastric cancer.Proteomic and metabolic prediction of response to therapy in gastric cancer.Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach.DNA and histone methylation in gastric carcinogenesisEpigenetics and colorectal cancer pathogenesisGastric cancer and related epigenetic alterations.Transcription control of DAPK.Methylated DNA for monitoring tumor growth and regression: how do we get there?DNA methylation and apoptosis resistance in cancer cellsBNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton.Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomasTranscription Factor AP2ε: A Potential Predictor of Chemoresistance in Patients With Gastric Cancer.Clinical significance of LMO1 in gastric cancer tissue and its association with apoptosis of cancer cells.Combination of platelet count and neutrophil-lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival in metastatic advanced gastric cancer.Nanoscale chromatin profiling of gastric adenocarcinoma reveals cancer-associated cryptic promoters and somatically acquired regulatory elements.Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer.
P2860
Q26741242-53C2750C-1091-477B-B113-B3AA8097AFBFQ27012898-C152CD7F-DDBB-4641-B3CC-E611E5AFCFDFQ28397621-DD42918D-CFCC-4198-B5A7-6159A21A6669Q34141405-FE070B00-9F1A-48DA-AB75-91B5FFB2CF1CQ34326627-BC61CBAA-55BA-4830-9130-F0B1DA0D7685Q34668730-418C3441-C0BC-4E3F-8270-51AA49D2962AQ35023839-5D614C33-82BB-4518-8044-365F7976F7D5Q35189387-B5B4FE98-8C3D-4702-BC48-57C3AEBA7076Q35336183-C349B9AB-0967-4F5D-8519-DEAC0D8D0A46Q35904485-ECC4AD23-41C1-4EAC-A51F-3A84457CFD5BQ36654458-C484C48A-EEF4-44D6-B0D0-5F0CA8914622Q37061792-7B03C283-65B0-4B32-9104-E212D6484C5CQ37592416-2C0D2B49-E036-4D92-9070-FCB347831861Q38161832-E6661679-C68A-4232-AD52-53B74E961C2EQ38194584-B60AFFC7-489D-4147-856E-7164D19B8011Q38202821-A68511AB-EFAA-436C-8A38-90946A71DFA6Q38593285-DE4DBC97-83AF-44DC-9C7F-0CB605D52951Q38663683-1345A320-6D1C-4AF1-8B2D-1C9E29C7C678Q38894951-73F23C17-85CC-4B03-82AF-B30E63FE0293Q49299930-42F43351-731E-4F72-9CFE-73DE6B76E230Q50083358-98E9C3ED-CBA7-4A49-9AE8-D39B14CBF1B8Q50649873-BE6CC5BB-C4C9-49A6-B933-54625BBB2494Q53071911-E3A9CF73-0DE4-4047-8E0B-753230D8BB8C
P2860
Methylation of BNIP3 and DAPK indicates lower response to chemotherapy and poor prognosis in gastric cancer.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Methylation of BNIP3 and DAPK ...... r prognosis in gastric cancer.
@en
Methylation of BNIP3 and DAPK ...... r prognosis in gastric cancer.
@nl
type
label
Methylation of BNIP3 and DAPK ...... r prognosis in gastric cancer.
@en
Methylation of BNIP3 and DAPK ...... r prognosis in gastric cancer.
@nl
prefLabel
Methylation of BNIP3 and DAPK ...... r prognosis in gastric cancer.
@en
Methylation of BNIP3 and DAPK ...... r prognosis in gastric cancer.
@nl
P2093
P356
P1433
P1476
Methylation of BNIP3 and DAPK ...... r prognosis in gastric cancer.
@en
P2093
Hirofumi Sugita
Hiroyuki Uetake
Hiroyuki Yamada
Kazuyuki Kojima
Keiji Kato
Kenichi Sugihara
Megumi Ishiguro
Megumu Enjoji
Satoru Iida
Toshiaki Ishikawa
P304
P356
10.3892/OR.2010.1085
P577
2010-12-08T00:00:00Z